TCDA - トリシダ (Tricida Inc.)

TCDAのニュース

   Tricida Inc Shares Close the Week 25.8% Lower - Weekly Wrap  2021/02/26 22:30:00 Kwhen Finance
Tricida Inc shares closed this week 25.8% lower than it did at the end of last week. The stock is currently down 27.5% year-to-date, down 83.9% over the past 12 months, and down 80.3% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Shares traded as high as $8.16 and as low as $4.85 this week.Shares closed 9e+1% below its 52-week high and 3e+1% above its 52-week low.Trading volume this week was 178.4% higher than the 10-day average and 396.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -149.7% The company's stock price performance over the past 12 months lags the peer average by -173.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Tricida, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm  2020/08/28 20:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $TCDA #TCDA--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Tricida, Inc.
   Tricida to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Thursday, May 7, 2020  2020/04/30 14:00:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2020 financial results after the close of market on Thursday, May 7, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows: Tricida First Quarter 2020 Conference Call Thursday, May 7, 2020 4:30 pm Eastern Time Webcast: IR.Tricida.com Dial-in:
   Tricida to Present at the Needham Virtual Healthcare Conference  2020/04/09 15:43:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020 at 6:20 am PT / 9:20 am ET. Tricida will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the presentation will be accessible on the Tricida website at IR.Tricida.com. An archive of the webcast will be available for 90 days following the pre
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
   Wilhelm Stahl Sells 836 Shares of Tricida Inc (NASDAQ:TCDA) Stock  2019/11/15 04:13:08 Modern Readers
Tricida Inc (NASDAQ:TCDA) VP Wilhelm Stahl sold 836 shares of Tricida stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $39.97, for a total value of $33,414.92. Following the transaction, the vice president now owns 15,642 shares in the company, valued at approximately $625,210.74. The […]

calendar